BioNTech SE (BNTX)
90.20
-0.68
(-0.75%)
USD |
NASDAQ |
May 08, 14:57
BioNTech Revenue (Quarterly): 203.77M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 203.77M |
| December 31, 2023 | 1.593B |
| September 30, 2023 | 974.79M |
| June 30, 2023 | 182.87M |
| March 31, 2023 | 1.372B |
| December 31, 2022 | 4.375B |
| September 30, 2022 | 3.487B |
| June 30, 2022 | 3.405B |
| March 31, 2022 | 7.153B |
| December 31, 2021 | 6.328B |
| September 30, 2021 | 7.177B |
| June 30, 2021 | 6.398B |
| Date | Value |
|---|---|
| March 31, 2021 | 2.468B |
| December 31, 2020 | 411.82M |
| September 30, 2020 | 78.93M |
| June 30, 2020 | 45.92M |
| March 31, 2020 | 30.57M |
| December 31, 2019 | 31.00M |
| September 30, 2019 | 31.87M |
| June 30, 2019 | 28.97M |
| March 31, 2019 | 29.71M |
| December 31, 2018 | 72.77M |
| September 30, 2018 | 23.72M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
28.97M
Minimum
Jun 2019
7.177B
Maximum
Sep 2021
2.289B
Average
1.173B
Median
Revenue (Quarterly) Benchmarks
| Pfizer Inc | 14.88B |
| Moderna Inc | 167.00M |
| Autolus Therapeutics PLC | -- |
| Novavax Inc | 253.40M |
| BioVie Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -342.26M |
| Total Expenses (Quarterly) | 754.69M |
| EPS Diluted (Quarterly) | -1.423 |
| Enterprise Value | 5.238B |
| Gross Profit Margin (Quarterly) | 68.50% |
| Profit Margin (Quarterly) | -168.0% |
| Earnings Yield | 0.53% |
| Normalized Earnings Yield | 0.7646 |